{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:03:14Z","timestamp":1792195394187,"version":"4.4.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","soard.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery for Obesity and Related Diseases"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.soard.2020.03.013","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T20:36:20Z","timestamp":1584736580000},"page":"1361-1369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review"],"prefix":"10.1016","volume":"16","author":[{"given":"Eider","family":"Talavera-Urquijo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Beisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Balibrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Alverdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cld.2015.10.001","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world","volume":"20","author":"Sayiner","year":"2016","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with nonalcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/hep.28677","article-title":"Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort","volume":"64","author":"Setiawan","year":"2016","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.soard.2020.03.013_bib5","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib6","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.soard.2020.03.013_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fendo.2014.00164","article-title":"Bariatric surgery and non-alcoholic fatty liver disease: current and potential future treatments","volume":"5","author":"Sasaki","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.soard.2020.03.013_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2015.09.004","article-title":"The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome","volume":"65","author":"Aguilar-Olivos","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib10","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.soard.2015.02.006","article-title":"The effect of surgically induced weight loss on nonalcoholic fatty liver disease in morbidly obese Indians: \u201cNASHOST\u201d prospective observational trial","volume":"11","author":"Praveen Raj","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s11695-011-0579-7","article-title":"Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients","volume":"22","author":"Tai","year":"2012","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","article-title":"Are we really vastly outnumbered? Revisiting the Ratio of bacterial to host cells in humans","volume":"164","author":"Sender","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.gastro.2008.10.080","article-title":"Microbes in gastrointestinal health and disease","volume":"136","author":"Neish","year":"2009","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"10.1016\/j.soard.2020.03.013_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000354902","article-title":"Clinical consequences of diet-induced dysbiosis","volume":"63","author":"Chan","year":"2013","journal-title":"Ann Nutr Metab"},{"issue":"7285","key":"10.1016\/j.soard.2020.03.013_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.soard.2020.03.013_bib16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11883-014-0454-9","article-title":"The effects of gastrointestinal surgery on gut microbiota: potential contribution to improved insulin sensitivity","volume":"16","author":"Aron-Wisnewsky","year":"2014","journal-title":"Curr Atheroscler Rep"},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib17","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2337\/db06-1491","article-title":"Metabolic endotoxemia initiates obesity and insulin resistance","volume":"56","author":"Cani","year":"2007","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2217\/fmb.11.142","article-title":"The relationship between gut microbiota and weight gain in humans","volume":"7","author":"Angelakis","year":"2012","journal-title":"Future Microbiol"},{"issue":"6150","key":"10.1016\/j.soard.2020.03.013_bib19","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","article-title":"Gut microbiota from twins discordant for obesity modulate metabolism in mice","volume":"341","author":"Ridaura","year":"2013","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.soard.2020.03.013_bib20","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1073\/pnas.0504978102","article-title":"Obesity alters gut microbial ecology","volume":"102","author":"Ley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","article-title":"The impact of the gut microbiota on human health: an integrative view","volume":"148","author":"Clemente","year":"2012","journal-title":"Cell"},{"issue":"44","key":"10.1016\/j.soard.2020.03.013_bib22","doi-asserted-by":"crossref","first-page":"16452","DOI":"10.3748\/wjg.v20.i44.16452","article-title":"Obesity, fatty liver disease and intestinal microbiota","volume":"20","author":"Arslan","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib24","first-page":"46","article-title":"Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats","volume":"33","author":"Wostmann","year":"1983","journal-title":"Lab Anim Sci"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib25","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3945\/ajcn.110.010132","article-title":"Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans","volume":"94","author":"Jumpertz","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib26","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1210\/en.2008-0059","article-title":"Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids","volume":"149","author":"Ge","year":"2008","journal-title":"Endocrinology"},{"issue":"28","key":"10.1016\/j.soard.2020.03.013_bib27","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.M301403200","article-title":"Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation","volume":"278","author":"Le Poul","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.smim.2011.11.011","article-title":"Immuno-microbiota cross and talk: the new paradigm of metabolic diseases","volume":"24","author":"Burcelin","year":"2012","journal-title":"Semin Immunol"},{"key":"10.1016\/j.soard.2020.03.013_bib29","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fcimb.2012.00132","article-title":"Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis","volume":"2","author":"Alisi","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00125-007-0654-8","article-title":"C3 H\/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet","volume":"50","author":"Poggi","year":"2007","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cmet.2009.09.006","article-title":"Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice","volume":"10","author":"Saberi","year":"2009","journal-title":"Cell Metab"},{"issue":"7384","key":"10.1016\/j.soard.2020.03.013_bib32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","article-title":"Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity","volume":"482","author":"Henao-Mejia","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib33","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","article-title":"Sensing and reacting to microbes through the inflammasomes","volume":"13","author":"Franchi","year":"2012","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib34","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/hep.21138","article-title":"Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver","volume":"43","author":"Gustot","year":"2006","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib35","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","article-title":"Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD)","volume":"57","author":"Volynets","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib36","first-page":"1635","article-title":"Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability","volume":"35","author":"Forsyth","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e3282fee935","article-title":"Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis","volume":"19","author":"Vance","year":"2008","journal-title":"Curr Opin Lipidol"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib38","first-page":"1399","article-title":"Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation","volume":"22","author":"Buchman","year":"1995","journal-title":"Hepatology"},{"issue":"7341","key":"10.1016\/j.soard.2020.03.013_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.suc.2018.12.003","article-title":"Bile metabolism and lithogenesis: an update","volume":"99","author":"Dosch","year":"2019","journal-title":"Surg Clin N Am"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tem.2017.11.002","article-title":"Role of bile acids in metabolic control","volume":"29","author":"Molinaro","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib42","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1194\/jlr.R054114","article-title":"Intestinal transport and metabolism of bile acids","volume":"56","author":"Dawson","year":"2015","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib43","doi-asserted-by":"crossref","first-page":"G209","DOI":"10.1152\/ajpgi.00121.2015","article-title":"Therapeutic targeting of bile acids","volume":"309","author":"Camilleri","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"5418","key":"10.1016\/j.soard.2020.03.013_bib44","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.soard.2020.03.013_bib45","doi-asserted-by":"crossref","first-page":"29749","DOI":"10.1074\/jbc.274.42.29749","article-title":"Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene. Involvement of the farnesoid X receptor\/9-cis-retinoic acid receptor heterodimer","volume":"274","author":"Grober","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"issue":"Pt 12","key":"10.1016\/j.soard.2020.03.013_bib47","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1099\/jmm.0.014092-0","article-title":"Effect of bile salts on the DNA and membrane integrity of enteric bacteria","volume":"58","author":"Merritt","year":"2009","journal-title":"J Med Microbiol"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib48","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","article-title":"Bile acid is a host factor that regulates the composition of the cecal microbiota in rats","volume":"141","author":"Islam","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.soard.2020.03.013_bib49","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3389\/fendo.2018.00530","article-title":"Weight-independent mechanisms of glucose control after Roux-en-Y gastric bypass","volume":"9","author":"Laferr\u00e8re","year":"2018","journal-title":"Front Endocrinol"},{"issue":"28","key":"10.1016\/j.soard.2020.03.013_bib50","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.4254\/wjh.v7.i28.2811","article-title":"Bile acid receptors and nonalcoholic fatty liver disease","volume":"7","author":"Yuan","year":"2015","journal-title":"World J Hepatol"},{"issue":"10","key":"10.1016\/j.soard.2020.03.013_bib51","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.soard.2020.03.013_bib52","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1055\/s-0036-1571296","article-title":"Nuclear receptor modulation for the treatment of nonalcoholic fatty liver disease","volume":"36","author":"Fuchs","year":"2016","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib54","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11883-015-0500-2","article-title":"FXR agonists as therapeutic agents for non-alcoholic fatty liver disease","volume":"17","author":"Carr","year":"2015","journal-title":"Curr Atheroscl Rep"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/hep.29199","article-title":"Hepatic FXR\/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice","volume":"66","author":"Kim","year":"2017","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.soard.2020.03.013_bib56","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD","volume":"67","author":"Jiao","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.soard.2020.03.013_bib57","doi-asserted-by":"crossref","first-page":"398585","DOI":"10.1155\/2015\/398585","article-title":"The interplay of the gut microbiome, bile acids, and volatile organic compounds","volume":"2015","author":"Sagar","year":"2015","journal-title":"Gastroenterol Res Pract"},{"issue":"7075","key":"10.1016\/j.soard.2020.03.013_bib58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib59","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0028-1091981","article-title":"Mechanisms of disease progression in nonalcoholic fatty liver disease","volume":"28","author":"Jou","year":"2008","journal-title":"Semin Liver Dis"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151829","article-title":"Bile acids and dysbiosis in non-alcoholic fatty liver disease","volume":"11","author":"Mouzaki","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib61","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/hep.29359","article-title":"The presence and severity of non-alcoholic steatohepatitis is associated with specific changes in circulating bile acids","volume":"67","author":"Puri","year":"2017","journal-title":"Hepatology"},{"issue":"9972","key":"10.1016\/j.soard.2020.03.013_bib62","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib63","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/dom.12681","article-title":"Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers","volume":"18","author":"Pencek","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib64","doi-asserted-by":"crossref","first-page":"E708","DOI":"10.1210\/jc.2012-3736","article-title":"Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids","volume":"98","author":"Kohli","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib65","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.28689","article-title":"Vertical sleeve gastrectomy activates GPBAR-1\/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice","volume":"64","author":"Ding","year":"2016","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib66","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2015-309871","article-title":"TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice","volume":"66","author":"McGavigan","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.soard.2020.03.013_bib67","unstructured":"Estimate of bariatric surgery numbers, 2011-2018 [https:\/\/asmbs.org\/]. Newberry: American Society for Metabolic and Bariatric Surgery; c2020 [updated 2018 Jun; cited 2019 Oct 4]. Available from: https:\/\/asmbs.org\/resources\/estimate-of-bariatric-surgery-numbers."},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib68","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s11695-015-1974-2","article-title":"Trends in bariatric surgery: procedure selection, revisional surgeries, and readmissions","volume":"26","author":"Abraham","year":"2016","journal-title":"Obes Surg"},{"issue":"8","key":"10.1016\/j.soard.2020.03.013_bib69","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s11695-016-2271-4","article-title":"Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)","volume":"26","author":"De Luca","year":"2016","journal-title":"Obes Surg"},{"issue":"10","key":"10.1016\/j.soard.2020.03.013_bib70","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.metabol.2009.05.006","article-title":"Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery","volume":"58","author":"Nakatani","year":"2009","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.soard.2020.03.013_bib71","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/en.2011-2145","article-title":"The role of bile after Roux- en-Y gastric bypass in promoting weight loss and improving glycaemic control","volume":"153","author":"Pournaras","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib72","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1053\/j.gastro.2011.05.008","article-title":"Sleeve gastrectomy in rats improves postprandial lipid clearance by reducing intestinal triglyceride secretion","volume":"141","author":"Stefater","year":"2011","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib73","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.2337\/db13-0022","article-title":"Exaggerated glucagon-like peptide 1 response is important for improved beta-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes","volume":"62","author":"Jorgensen","year":"2013","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib74","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/oby.2009.102","article-title":"Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism","volume":"17","author":"Patti","year":"2009","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.soard.2020.03.013_bib75","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3109\/00365521.2013.833647","article-title":"Enhanced fasting and post-prandial plasma bile acid responses after Roux-en-Y gastric bypass surgery","volume":"48","author":"Werling","year":"2013","journal-title":"Scand J Gastroenterol"},{"issue":"12","key":"10.1016\/j.soard.2020.03.013_bib76","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1038\/ijo.2013.38","article-title":"Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity","volume":"37","author":"Ahmad","year":"2013","journal-title":"Int J Obes"},{"issue":"12","key":"10.1016\/j.soard.2020.03.013_bib77","doi-asserted-by":"crossref","first-page":"E660","DOI":"10.1002\/oby.20522","article-title":"Bile acids and gut peptide secretion after bariatric surgery: a 1-year prospective randomized pilot trial","volume":"21","author":"Steinert","year":"2013","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.soard.2020.03.013_bib78","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11695-015-1834-0","article-title":"FGF 19 and bile acids increase following Roux-en-Y gastric bypass but not after medical management in patients with type 2 diabetes","volume":"26","author":"Sachdev","year":"2016","journal-title":"Obes Surg"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib79","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/ijo.2015.250","article-title":"Temporal changes in bile acid levels and 12 alpha-hydroxylation after Roux-en-Y gastric bypass surgery in type 2 diabetes","volume":"40","author":"Dutia","year":"2016","journal-title":"Int J Obes"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib80","doi-asserted-by":"crossref","first-page":"E396","DOI":"10.1210\/jc.2014-1658","article-title":"Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations","volume":"100","author":"J\u00f8rgensen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib81","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.soard.2017.05.024","article-title":"Bile acid profiles over 5 years after gastric bypass and duodenal switch: results from a randomized clinical trial","volume":"13","author":"Risstad","year":"2017","journal-title":"Surg Obes Relat Dis"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib82","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s11695-015-1878-1","article-title":"Changes in bile acid profile after laparoscopic sleeve gastrectomy are associated with improvements in metabolic profile and fatty liver disease","volume":"26","author":"Belgaumkar","year":"2016","journal-title":"Obes Surg"},{"issue":"9","key":"10.1016\/j.soard.2020.03.013_bib83","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/bjs.11208","article-title":"Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity","volume":"106","author":"Ahlin","year":"2019","journal-title":"BJS"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib84","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.soard.2015.11.015","article-title":"Bile acids synthesis decreases after laparoscopic sleeve gastrectomy","volume":"12","author":"Escalona","year":"2016","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib85","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000324128","article-title":"Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery","volume":"29","author":"Jansen","year":"2011","journal-title":"Dig Dis"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib86","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/en.2003-1671","article-title":"Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin- deficient diabetes","volume":"145","author":"Fu","year":"2004","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.soard.2020.03.013_bib87","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmet.2011.03.019","article-title":"FGF15\/19 regulates hepatic glucose metabolism by inhibiting the CREB- PGC-1 \u03b1 pathway","volume":"13","author":"Potthoff","year":"2011","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib88","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/oby.20208","article-title":"Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects: FGF-19 and -21 after sleeve gastrectomy","volume":"21","author":"Haluz\u00edkov\u00e1","year":"2013","journal-title":"Obesity"},{"issue":"13","key":"10.1016\/j.soard.2020.03.013_bib89","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor- dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"issue":"10","key":"10.1016\/j.soard.2020.03.013_bib90","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41575-018-0057-y","article-title":"Gut adaptation after metabolic surgery and its influences on the brain, liver and cancer","volume":"15","author":"Sinclair","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.soard.2020.03.013_bib91","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1002\/oby.20890","article-title":"The role of small heterodimer partner in nonalcoholic fatty liver disease improvement after sleeve gastrectomy in mice","volume":"22","author":"Myronovych","year":"2014","journal-title":"Obesity"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib92","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ijo.2017.7","article-title":"Roux-en-Y gastric bypass increases systemic but not portal bile acid concentrations by decreasing hepatic bile acid uptake in minipigs","volume":"41","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10.1016\/j.soard.2020.03.013_bib93","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.livres.2017.12.007","article-title":"Bile acid signaling and bariatric surgery","volume":"1","author":"Tian","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.soard.2020.03.013_bib94","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3389\/fendo.2019.00611","article-title":"Gut dysfunction and non-alcoholic fatty liver disease","volume":"10","author":"Grabherr","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.soard.2020.03.013_bib95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1530\/EJE-17-0403","article-title":"Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery","volume":"178","author":"Guo","year":"2018","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.soard.2020.03.013_bib96","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1073\/pnas.0812600106","article-title":"Human gut microbiota in obesity and after gastric bypass","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.soard.2020.03.013_bib97","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2337\/db10-0253","article-title":"Differential adaptation of human gut microbiota to bariatric surgery- induced weight loss: links with metabolic and low- grade inflammation markers","volume":"59","author":"Furet","year":"2010","journal-title":"Diabetes"},{"issue":"178","key":"10.1016\/j.soard.2020.03.013_bib98","doi-asserted-by":"crossref","first-page":"178 ra141","DOI":"10.1126\/scitranslmed.3005687","article-title":"Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity","volume":"5","author":"Liou","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib99","first-page":"229","article-title":"Association of pro- inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease","volume":"136","author":"Kumar","year":"2012","journal-title":"Indian J Med Res"},{"issue":"3","key":"10.1016\/j.soard.2020.03.013_bib100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/jam.13158","article-title":"Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob\/ob mice","volume":"121","author":"Park","year":"2016","journal-title":"J Appl Microbiol"},{"issue":"2","key":"10.1016\/j.soard.2020.03.013_bib101","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1574-6968.2009.01531.x","article-title":"Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces","volume":"293","author":"Fukiya","year":"2009","journal-title":"FEMS Microbiol Lett"}],"container-title":["Surgery for Obesity and Related Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728920301313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1550728920301313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:15:07Z","timestamp":1761552907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1550728920301313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1550728920301313"],"URL":"https:\/\/doi.org\/10.1016\/j.soard.2020.03.013","relation":{},"ISSN":["1550-7289"],"issn-type":[{"value":"1550-7289","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is bariatric surgery resolving NAFLD via microbiota-mediated bile acid ratio reversal? A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Surgery for Obesity and Related Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soard.2020.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}